Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study

• URL: http://arxiv.org/abs/2605.10278v1
• Date: Mon, 11 May 2026 09:38:40 GMT
• Title: Predictive Radiomics for Evaluation of Cancer Immune SignaturE in Glioblastoma: the PRECISE-GBM study
• Abstract summary: Radiogenomic models non-invasively predicted the macrophage subtype M0 immune signature in IDH-wildtype glioblastoma.<n>These biomarkers have the potential to stratify patients for immunotherapy within prospective glioblastoma clinical trials.
• Score: 5.798780829165377
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Background: Radiogenomics allows identification of radiological biomarkers for genomic phenotypes. In glioblastoma, these biomarkers could potentially complement patient stratification strategies. We aim to develop and analytically validate radiological biomarkers that capture immune cell signatures within IDH-wildtype glioblastoma microenvironment using radiogenomic analysis. Methods: This was a retrospective multicenter study using curated open-access anonymized imaging and genomic data from TCGA-GBM, CPTAC, IvyGAP, REMBRANDT and CGGA datasets. Imaging data consisted of MRI-based radiomic features extracted from necrotic core, enhancing and edema regions of deep learning-based auto-segmented tumors. Radiomic feature selections were performed using nested cross-validated LASSO. Support vector machine and ensemble models were trained using seventeen immune and cell-specific score labels extracted from deconvoluted transcriptomic data using pan-cancer and glioblastoma immune signature matrices as reference standards. Seventeen classifier models trained in three cross-cohort strategies were validated on three held-out datasets assessing stability and generalizability. Results: One-hundred-and-seventy-six patients were included in the study. The immune-related radiomic signatures obtained after feature selection were shape, first order and higher order radiomic features. Models predicting macrophage subtype immune signature showed stable mean performance on balanced accuracy (0.67) and precision (0.89) metrics for three independent holdout datasets with ensemble model outperforming support vector machine model. Conclusion: Radiogenomic models non-invasively predicted the macrophage subtype M0 immune signature in IDH-wildtype glioblastoma. These biomarkers have the potential to stratify patients for immunotherapy within prospective glioblastoma clinical trials.

Related papers

• Segmentation Robustness and Predictive Utility in Glioblastoma Radiomics: Evidence for a Trade-off in Survival Modelling [0.0]
  Radiomic biomarkers have been widely investigated as non-invasive tools for tumor characterization and prognostic modeling in glioblastoma (GBM)<n>In this study, we investigate the relationship between feature robustness and predictive utility in GBM survival modeling.<n>Findings suggest that robustness alone is not a reliable criterion for feature selection in radiomics-based survival modelling.
  arXiv  Detail & Related papers  (2026-07-26T12:20:08Z)
• Benchmarking Machine Learning Models for Multi-Omics-Based Breast Cancer Prediction [0.0]
  Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection.<n>This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction.
  arXiv  Detail & Related papers  (2026-06-27T02:46:40Z)
• Pan-Cancer Mapping of the Tumor Immune Landscape through Metagene Clustering and Predictive Modeling [0.40611352512781856]
  Despite advances in immune profiling, the mechanisms driving immune phenotypes remain unclear.<n>This study aimed to identify novel, robust immune-related gene clusters (metagenes)<n>Genes were ranked by differential expression between high- and low-expression groups.
  arXiv  Detail & Related papers  (2026-03-28T05:38:40Z)
• Explainable Deep Radiogenomic Molecular Imaging for MGMT Methylation Prediction in Glioblastoma [0.7614628596146601]
  The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter is a critical molecular biomarker.<n>Traditional methods for determining MGMT status rely on invasive biopsies.<n>This study presents a radiogenomic molecular imaging analysis framework for the non-invasive prediction of MGMT promoter methylation.
  arXiv  Detail & Related papers  (2026-01-11T19:16:19Z)
• Systematic Review of Pituitary Gland and Pituitary Adenoma Automatic Segmentation Techniques in Magnetic Resonance Imaging [40.16592757754337]
  We reviewed 34 studies that employed automatic and semi-automatic segmentation methods.<n>The majority of reviewed studies utilized deep learning approaches, with U-Net-based models being the most prevalent.<n>Further improvements are needed to achieve consistently good performance in small structures like the normal pituitary gland.
  arXiv  Detail & Related papers  (2025-06-24T17:05:01Z)
• Interpretable Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification using Multi-Omics Data [36.92842246372894]
  Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN) is a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples.<n>By integrating multi-omics data with graph-based deep learning, our proposed approach demonstrates robust predictive performance and interpretability.
  arXiv  Detail & Related papers  (2025-03-29T02:14:05Z)
• MGH Radiology Llama: A Llama 3 70B Model for Radiology [50.42811030970618]
  This paper presents an advanced radiology-focused large language model: MGH Radiology Llama.<n>It is developed using the Llama 3 70B model, building upon previous domain-specific models like Radiology-GPT and Radiology-Llama2.<n>Our evaluation, incorporating both traditional metrics and a GPT-4-based assessment, highlights the enhanced performance of this work over general-purpose LLMs.
  arXiv  Detail & Related papers  (2024-08-13T01:30:03Z)
• Generating counterfactual explanations of tumor spatial proteomes to discover effective strategies for enhancing immune infiltration [44.99833362998488]
  The tumor microenvironment (TME) significantly impacts cancer prognosis due to its immune composition. Here, we formulate T-cell infiltration prediction as a self-supervised machine learning problem. We apply our framework to melanoma, colorectal cancer liver metastases, and breast tumor data, discovering perturbations predicted to support T-cell infiltration.
  arXiv  Detail & Related papers  (2022-11-08T05:46:02Z)
• Deep radiomic signature with immune cell markers predicts the survival of glioma patients [8.386631203775533]
  We propose a novel type of deep radiomic features (DRFs) computed from a convolutional neural network (CNN) The proposed method extracts a total of 180 DRFs by aggregating the activation maps of a pre-trained 3D-CNN within labeled tumor regions of MRI scans. Results show a high correlation between DRFs and various markers, as well as significant differences between patients grouped based on these markers.
  arXiv  Detail & Related papers  (2022-06-09T08:52:15Z)
• Modeling of Textures to Predict Immune Cell Status and Survival of Brain Tumour Patients [4.542148087324063]
  Radiomics has shown a capability for different types of cancers such as glioma to predict the clinical outcome. We aim to predict the immune marker status (low versus high) and overall survival for glioma patients using deep radiomic features (DRFs) Our experiments are performed to assess the relationship between the proposed DRFs, three immune cell markers (Macrophage M1, Neutrophils and T Cells Follicular Helper) and measure their association with overall survival.
  arXiv  Detail & Related papers  (2022-06-04T03:52:12Z)
• Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types [41.61294299606317]
  Tumor mutational burden (TMB) is a potential genomic biomarker of immunotherapy. TMB detected through whole exome sequencing lacks clinical penetration in low-resource settings. In this study, we proposed a multi-scale deep learning framework to address the detection of TMB status from routinely used whole slide images.
  arXiv  Detail & Related papers  (2022-04-07T07:02:32Z)
• Novel Local Radiomic Bayesian Classifiers for Non-Invasive Prediction of MGMT Methylation Status in Glioblastoma [0.0]
  Expression of the O6-methylguanine-DNA-methyltransferase (MGMT) gene in glioblastoma tumor tissue is of clinical importance. Currently, MGMT methylation is determined through an invasive brain biopsy and subsequent genetic analysis of the extracted tumor tissue. We present novel Bayesian classifiers that make probabilistic predictions of MGMT methylation status based on radiomic features extracted from FLAIR-sequence magnetic resonance imagery (MRIs)
  arXiv  Detail & Related papers  (2021-11-30T04:53:23Z)
• Cancer Gene Profiling through Unsupervised Discovery [49.28556294619424]
  We introduce a novel, automatic and unsupervised framework to discover low-dimensional gene biomarkers. Our method is based on the LP-Stability algorithm, a high dimensional center-based unsupervised clustering algorithm. Our signature reports promising results on distinguishing immune inflammatory and immune desert tumors.
  arXiv  Detail & Related papers  (2021-02-11T09:04:45Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)
• Topological Data Analysis of copy number alterations in cancer [70.85487611525896]
  We explore the potential to capture information contained in cancer genomic information using a novel topology-based approach. We find that this technique has the potential to extract meaningful low-dimensional representations in cancer somatic genetic data.
  arXiv  Detail & Related papers  (2020-11-22T17:31:23Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.